A Novel Method for the Synthesis of <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" style="vertical-align:-4.940201pt" id="M1" height="20.3649pt" version="1.1" viewBox="-0.0657574 -15.4247 38.7411 20.3649" width="38.7411pt"><g transform="matrix(.012,0,0,-0.012,0,-7.751)"><path id="g190-193" d="M247 635C117 635 41 518 41 422C41 317 114 239 220 239C239 239 256 244 278 255L348 290C315 139 207 37 63 13L67 -15C93 -15 155 -5 207 17C343 71 443 203 443 385C443 520 371 635 247 635ZM231 602C331 602 355 476 355 390C355 371 354 349 351 325C334 310 298 294 261 294C177 294 128 369 128 457C128 516 155 602 231 602Z"/></g><g transform="matrix(.012,0,0,-0.012,5.947,-7.751)"><use xlink:href="#g190-193"/></g><g transform="matrix(.012,0,0,-0.012,11.809,-7.751)"><path id="g190-110" d="M797 0V26C739 32 732 36 732 103V296C732 394 682 449 605 449C576 449 550 437 529 423C504 407 475 389 446 366C425 418 382 449 334 449C303 449 279 437 253 421C222 403 201 385 180 371V452C135 432 85 419 41 411V388C99 379 102 374 102 310V103C102 38 93 32 27 26V0H238V26C189 32 180 38 180 103V338C210 363 250 390 289 390C351 390 377 348 377 275V103C377 37 368 32 306 26V0H520V26C465 32 456 38 456 101V296C456 314 455 326 453 338C491 369 529 390 565 390C628 390 653 345 653 274V107C653 36 642 32 583 26V0H797Z"/></g><g transform="matrix(.017,0,0,-0.017,22.385,0)"><path id="g190-85" d="M592 498C586 556 582 629 581 675H560C545 656 537 650 510 650H115C87 650 74 652 60 675H40C38 620 33 555 28 495H57C69 539 77 568 89 585C102 607 122 616 205 616H267V123C267 44 259 34 168 28V0H454V28C360 34 352 44 352 123V616H422C498 616 514 608 531 584C542 568 552 543 562 495L592 498Z"/></g><g transform="matrix(.017,0,0,-0.017,31.284,0)"><path id="g190-100" d="M390 111C344 68 312 56 269 56C212 56 118 102 118 241C118 346 175 401 241 401C277 401 312 388 342 360C350 352 355 349 361 349C372 349 394 371 394 392C394 403 391 411 378 422C362 436 329 449 288 449H287C250 449 190 432 138 392C71 341 37 274 37 197C37 90 112 -12 238 -12C297 -12 363 32 407 90L390 111Z"/></g></svg>-Ofloxacin Kits Using D-Penicillamine as Coligand and Their Application as Infection Imaging Agent

<div>Biodistribution of <svg height="15.4006pt" id="M27" style="vertical-align:-3.7426pt" version="1.1" viewbox="-0.0498162 -11.658 29.7042 15.4006" width="29.7042pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0091,0,0,-0.0091,0,-5.872)"><path d="M247 635C116 635 39 517 39 421C39 315 112 237 221 237C240 237 258 241 281 253L349 289C314 140 205 42 60 19L66 -15C90 -15 153 -6 207 16C344 70 447 199 447 385C447 521 373 635 247 635ZM231 598C329 598 356 478 356 390C356 371 355 348 352 325C329 309 297 297 262 297C179 297 127 369 127 456C127 515 155 598 231 598Z" id="g58-55"></path><glyph.data ascent="1007" descent="-369" horiz-adv-x="487" vert-adv-y="487"></glyph.data></g><g transform="matrix(.0091,0,0,-0.0091,4.432,-5.872)"><path d="M247 635C116 635 39 517 39 421C39 315 112 237 221 237C240 237 258 241 281 253L349 289C314 140 205 42 60 19L66 -15C90 -15 153 -6 207 16C344 70 447 199 447 385C447 521 373 635 247 635ZM231 598C329 598 356 478 356 390C356 371 355 348 352 325C329 309 297 297 262 297C179 297 127 369 127 456C127 515 155 598 231 598Z" id="g58-55"></path><glyph.data ascent="1007" descent="-369" horiz-adv-x="487" vert-adv-y="487"></glyph.data></g><g transform="matrix(.0091,0,0,-0.0091,8.897,-5.872)"><path d="M810 0V30C751 35 744 40 744 106V296C744 396 694 451 614 451C583 451 558 438 537 425C512 409 485 391 454 368C434 420 390 451 342 451C309 451 285 439 260 424C228 405 206 387 185 372V453C141 434 90 421 43 413V386C102 378 105 373 105 309V106C105 41 96 35 29 30V0H243V30C194 35 185 41 185 106V335C216 360 256 389 297 389C357 389 384 348 384 275V106C384 41 374 35 312 30V0H530V30C475 35 465 41 465 104V294C465 313 464 324 463 336C502 367 539 389 576 389C637 389 663 346 663 274V109C663 41 653 35 593 30V0H810Z" id="g58-107"></path><glyph.data ascent="1007" descent="-369" horiz-adv-x="834" vert-adv-y="834"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,17.013,0)"><path d="M601 496C596 555 591 627 591 675H567C551 656 544 650 516 650H120C91 650 79 651 64 675H41C38 619 34 555 29 492H63C75 537 83 566 96 582C110 604 128 612 207 612H272V126C272 46 264 38 170 33V0H464V33C368 38 359 48 359 126V612H430C502 612 520 605 535 582C547 566 556 541 567 492L601 496Z" id="g58-82"></path><glyph.data ascent="1007" descent="-369" horiz-adv-x="628" vert-adv-y="628"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,23.937,0)"><path d="M396 114C349 71 317 59 274 59C216 59 123 104 123 241C123 342 180 400 246 400C283 400 317 386 348 359C355 352 361 348 366 348C378 348 401 371 402 394C402 405 398 413 385 424C369 437 337 451 294 451H293C254 451 193 434 141 394C73 342 39 277 39 198C39 90 114 -12 243 -12C303 -12 371 31 415 90L396 114Z" id="g58-97"></path><glyph.data ascent="1007" descent="-369" horiz-adv-x="432" vert-adv-y="432"></glyph.data></g></svg>-ofloxacin in normal rabbit (perfusion 0–30 sec.).</div>

BioMed Research International

fig4

Figure 4

Figure 4: A Novel Method for the Synthesis of <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" style="vertical-align:-4.940201pt" id="M1" height="20.3649pt" version="1.1" viewBox="-0.0657574 -15.4247 38.7411 20.3649" width="38.7411pt"><g transform="matrix(.012,0,0,-0.012,0,-7.751)"><path id="g190-193" d="M247 635C117 635 41 518 41 422C41 317 114 239 220 239C239 239 256 244 278 255L348 290C315 139 207 37 63 13L67 -15C93 -15 155 -5 207 17C343 71 443 203 443 385C443 520 371 635 247 635ZM231 602C331 602 355 476 355 390C355 371 354 349 351 325C334 310 298 294 261 294C177 294 128 369 128 457C128 516 155 602 231 602Z"/></g><g transform="matrix(.012,0,0,-0.012,5.947,-7.751)"><use xlink:href="#g190-193"/></g><g transform="matrix(.012,0,0,-0.012,11.809,-7.751)"><path id="g190-110" d="M797 0V26C739 32 732 36 732 103V296C732 394 682 449 605 449C576 449 550 437 529 423C504 407 475 389 446 366C425 418 382 449 334 449C303 449 279 437 253 421C222 403 201 385 180 371V452C135 432 85 419 41 411V388C99 379 102 374 102 310V103C102 38 93 32 27 26V0H238V26C189 32 180 38 180 103V338C210 363 250 390 289 390C351 390 377 348 377 275V103C377 37 368 32 306 26V0H520V26C465 32 456 38 456 101V296C456 314 455 326 453 338C491 369 529 390 565 390C628 390 653 345 653 274V107C653 36 642 32 583 26V0H797Z"/></g><g transform="matrix(.017,0,0,-0.017,22.385,0)"><path id="g190-85" d="M592 498C586 556 582 629 581 675H560C545 656 537 650 510 650H115C87 650 74 652 60 675H40C38 620 33 555 28 495H57C69 539 77 568 89 585C102 607 122 616 205 616H267V123C267 44 259 34 168 28V0H454V28C360 34 352 44 352 123V616H422C498 616 514 608 531 584C542 568 552 543 562 495L592 498Z"/></g><g transform="matrix(.017,0,0,-0.017,31.284,0)"><path id="g190-100" d="M390 111C344 68 312 56 269 56C212 56 118 102 118 241C118 346 175 401 241 401C277 401 312 388 342 360C350 352 355 349 361 349C372 349 394 371 394 392C394 403 391 411 378 422C362 436 329 449 288 449H287C250 449 190 432 138 392C71 341 37 274 37 197C37 90 112 -12 238 -12C297 -12 363 32 407 90L390 111Z"/></g></svg>-Ofloxacin Kits Using D-Penicillamine as Coligand and Their Application as Infection Imaging Agent 

BioMed Research International

A Novel Method for the Synthesis of -Ofloxacin Kits Using D-Penicillamine as Coligand and Their Application as Infection Imaging Agent

Figure 4